Hyperosmolar Therapy for the Intracranial Hypertension in Neurosurgical Practice: Mannitol Versus Hypertonic Saline
DOI:
https://doi.org/10.14205/2310-9394.2013.01.01.7Keywords:
Hyperosmolar therapy, Mannitol, Hypertonic saline, Intracranial pressure, Neurosurgery.Abstract
Management of cerebral edema and elevated intracranial pressure (ICP) is a critical determinant of patient outcomes. Osmotherapy is the most important options in the medical treatments including controlled ventilation, osmotherapy, maintenance of brain and body homeostasis and sedation. Mannitol and hypertonic saline (HTS) are frequently used among osmotic agents related to brain edema and high ICP. Although mannitol is recommended in guidelines, hypertonic saline seems advantageous over mannitol in many situations, such as providing sustained hemodynamic stability and immunologic effects and less rebound phenomenon. Thus, HTS is emerging as a secure alternative to mannitol in the treatment of intracranial hypertension.
References
Lazaridis C, Neyens R, Bodle J, DeSantis SM. Highosmolarity saline in neurocritical care: systematic review and meta-analysis. Crit Care Med [Comparative Study; Journal Article; Meta-Analysis; Review] 2013 2013-05-01; 41(5): 1353-60.
Ogden AT, Mayer SA, Connolly EJ. Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery [Journal Article; Review] 2005 2005-08-01; 57(2): 207-15, 207-15.
Knapp JM. Hyperosmolar therapy in the treatment of severe head injury in children: mannitol and hypertonic saline. AACN Clin Issues [Journal Article; Review] 2005 2005-04-01; 16(2): 199-211.
Helmy A, Vizcaychipi M, Gupta AK. Traumatic brain injury: intensive care management. Brit J Anaesth 2007; 99(1): 32- 42. http://dx.doi.org/10.1093/bja/aem139
Morgenstern LB, Hemphill JC, Anderson C, Becker K, Broderick JP, Connolly ES, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2010; 41(9): 2108-29. http://dx.doi.org/10.1161/STR.0b013e3181ec611b
Bederson JB, Connolly ES, Batjer HH, Dacey RG, Dion JE, Diringer MN, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage a statement for healthcare professionals from a special Writing Group of the Stroke Council, American Heart Association. Stroke 2009; 40(3): 994-1025. http://dx.doi.org/10.1161/STROKEAHA.108.191395
Adams HP, Del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the Early Management of Adults With Ischemic Stroke A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007; 115(20): e478-534. http://dx.doi.org/10.1161/CIRCULATIONAHA.107.181486
Mortazavi MM, Romeo AK, Deep A, Griessenauer CJ, Shoja MM, Tubbs RS, et al. Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis. J Neurosurg 2011; 116(1): 210-21.
Wise BL, Chater N. Effect of mannitol on cerebrospinal fluid pressure: the actions of hypertonic mannitol solutions and of urea compared. Arch Neurol-Chicago 1961; 4(2): 200. http://dx.doi.org/10.1001/archneur.1961.00450080082009
Bullock R. Mannitol and other diuretics in severe neurotrauma. New horizons (Baltimore, Md.) 1995; 3(3): 448- 52.
Yanko JR, Mitcho K. Acute care management of severe traumatic brain injuries. Crit Care Nursing Quart 2001; 23(4): 1-23. http://dx.doi.org/10.1097/00002727-200102000-00002
Adelson PD, Bratton SL, Carney NA, Chesnut RM, Du Coudray HE, Goldstein B, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 5. Indications for intracranial pressure monitoring in pediatric patients with severe traumatic brain injury. Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2003; 4(3 Suppl): S19.
Olson JE, Banks M, Dimlich RV, Evers J. Blood brain barrier water permeability and brain osmolyte content during edema development. Acad Emerg Med 1997; 4(7): 662-73. http://dx.doi.org/10.1111/j.1553-2712.1997.tb03757.x
Rosenberg GA, Kyner WT, Fenstermacher JD, Patlak CS. Effect of vasopressin on ependymal and capillary permeability to tritiated water in cat. Am J Physiol-Renal 1986; 251(3): F485-9.
Bhardwaj A. Osmotherapy in neurocritical care. Curr Neurol Neurosci Rep 2007; 7(6): 513-21. http://dx.doi.org/10.1007/s11910-007-0079-2
Lossinsky AS, Shivers RR. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Rev Histol Histopathol 2004; 19(2): 535-64.
Doyle JA, Davis DP, Hoyt DB. The use of hypertonic saline in the treatment of traumatic brain injury. J Trauma Acute Care Surgery 2001; 50(2): 367-83. http://dx.doi.org/10.1097/00005373-200102000-00030
Carvalho WBD. Hypertonic solutions for pediatric patients. J de Pediatria 2003; 79: S187-94. http://dx.doi.org/10.2223/JPED.1095
Zhao L, Wang B, You G, Wang Z, Zhou H. Effects of different resuscitation fluids on the rheologic behavior of red blood cells, blood viscosity and plasma viscosity in experimental hemorrhagic shock. Resuscitation 2009; 80(2): 253-8. http://dx.doi.org/10.1016/j.resuscitation.2008.10.014
Rocha-e-Silva M, Poli De Figueiredo LF. Small volume hypertonic resuscitation of circulatory shock. Clinics 2005; 60(2): 159-72. http://dx.doi.org/10.1590/S1807-59322005000200013
Ravussin P, Archer DP, Tyler JL, Meyer E, Abou-Madi M, Diksic M, et al. Effects of rapid mannitol infusion on cerebral blood volume: a positron emission tomographic study in dogs and man. J Neurosurg 1986; 64(1): 104-13. http://dx.doi.org/10.3171/jns.1986.64.1.0104
Andrews RJ, Bringas JR, Muto RP. Effects of mannitol on cerebral blood flow, blood pressure, blood viscosity, hematocrit, sodium, and potassium. Surg Neurol 1993; 39(3): 218-22. http://dx.doi.org/10.1016/0090-3019(93)90186-5
Hariri RJ, Ghajar JB, Pomerantz KB, Hajjar DP, Giannuzzi RF, Tomich E, et al. Human glial cell production of lipoxygenase-generated eicosanoids: a potential role in the pathophysiology of vascular changes following traumatic brain injury. J Trauma Acute Care Surg 1989; 29(9): 1203- 10. http://dx.doi.org/10.1097/00005373-198909000-00003
Angle N, Cabello-Passini R, Hoyt DB, Loomis WH, Shreve A, Namiki S, et al. Hypertonic saline infusion: can it regulate human neutrophil function? Shock 2000; 14(5): 503-8. http://dx.doi.org/10.1097/00024382-200014050-00002
Hartl R, Medary MB, Ruge M, Arfors KE, Ghahremani F, Ghajar J. Hypertonic/hyperoncotic saline attenuates microcirculatory disturbances after traumatic brain injury. J Trauma Acute Care Surg 1997; 42(5S): 41S-47S. http://dx.doi.org/10.1097/00005373-199705001-00008
Rizoli SB, Rhind SG, Shek PN, Inaba K, Filips D, Tien H, et al. The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial. Ann Surg 2006; 243(1): 47. http://dx.doi.org/10.1097/01.sla.0000193608.93127.b1
Coimbra R, Hoyt DB, Junger WG, Angle N, Wolf P, Loomis W, et al. Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock. J Trauma Acute Care Surg 1997; 42(4): 602-7. http://dx.doi.org/10.1097/00005373-199704000-00004
Charalambous MP, Swoboda SM, Lipsett PA. Perioperative hypertonic saline may reduce postoperative infections and lower mortality rates. Surg Infect 2008; 9(1): 67-74. http://dx.doi.org/10.1089/sur.2005.069
Worthley LI, Cooper DJ, Jones N. Treatment of resistant intracranial hypertension with hypertonic saline: Report of two cases. J Neurosurg 1988; 68(3): 478-81. http://dx.doi.org/10.3171/jns.1988.68.3.0478
Prough DS, Johnson JC, Stump DA, Stullken EH, Poole Jr GV, Howard G. Effects of hypertonic saline versus lactated Ringer's solution on cerebral oxygen transport during resuscitation from hemorrhagic shock. J Neurosurg 1986; 64(4): 627-32. http://dx.doi.org/10.3171/jns.1986.64.4.0627
Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000; 28(9): 3301-13. http://dx.doi.org/10.1097/00003246-200009000-00032
Wakai A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2007; 3.
Bereczki D, Fekete I, Prado GF, Liu M. Mannitol for acute stroke. Cochrane Database Syst Rev 2007; 3.
Oddo M, Levine JM, Frangos S, Carrera E, MaloneyWilensky E, Pascual JL, et al. Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neurosurg Psychiatry. [Journal Article; Research Support, Non-U.S. Gov't]. 2009 2009-08- 01; 80(8): 916-20.
Upadhyay P, Tripathi VN, Singh RP, Sachan D. Role of hypertonic saline and mannitol in the management of raised intracranial pressure in children: A randomized comparative study. J Pediatr Neurosci [Journal Article] 2010 2010-01-01; 5(1): 18-21.
Torre-Healy A, Marko NF, Weil RJ. Hyperosmolar therapy for intracranial hypertension. Neurocrit Care 2012; 17(1): 117- 30. http://dx.doi.org/10.1007/s12028-011-9649-x
Kamel H, Navi BB, Nakagawa K, Hemphill III JC, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: A meta-analysis of randomized clinical trials*. Crit Care Med 2011; 39(3): 554-9. http://dx.doi.org/10.1097/CCM.0b013e318206b9be
Hays AN, Lazaridis C, Neyens R, Nicholas J, Gay S, Chalela JA. Osmotherapy: use among neurointensivists. Neurocrit Care 2011; 14(2): 222-8. http://dx.doi.org/10.1007/s12028-010-9477-4
Marko NF. Hypertonic saline, not mannitol, should be considered gold-standard medical therapy for intracranial hypertension. Crit Care [Journal Article; Research Support, Non-U.S. Gov't; Review] 2012 2012-01-20; 16(1): 113.
White H, Cook D, Venkatesh B. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesthesia Analgesia 2006; 102(6): 1836-46. http://dx.doi.org/10.1213/01.ane.0000217208.51017.56
Paczynski RP. Osmotherapy: basic concepts and controversies. Crit Care Clin 1997; 13(1): 105-29. http://dx.doi.org/10.1016/S0749-0704(05)70298-0
Strandvik GF. Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure*. Anaesthesia 2009; 64(9): 990-1003. http://dx.doi.org/10.1111/j.1365-2044.2009.05986.x
Visweswaran P, Massin EK, Dubose TD. Mannitol-induced acute renal failure. J Am Soc Nephrol 1997; 8(6): 1028-33.
Rabetoy GM, Fredericks MR, Hostettler CF. Where the kidney is concerned, how much mannitol is too much? Ann Pharmacother 1993; 27(1): 25-8.
Oken DE. Renal and extrarenal considerations in high-dose mannitol therapy. Renal Failure 1994; 16(1): 147-59. http://dx.doi.org/10.3109/08860229409044856
Fang L, You H, Chen B, Xu Z, Gao L, Liu J, et al. Mannitol is an independent risk factor of acute kidney injury after cerebral trauma: a case-control study. Renal Failure 2010; 32(6): 673-9. http://dx.doi.org/10.3109/0886022X.2010.486492
